Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing — Oct 8th, 2024

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer goods, and other industries. Powered by RheoGuide™ Software, a streamlined, modern touc...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing — Oct 8th, 2024

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer goods, and other industries. Powered by RheoGuide™ Software, a streamlined, modern touc...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 10th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing — Oct 8th, 2024

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer goods, and other industries. Powered by RheoGuide™ Software, a streamlined, modern touc...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing — Oct 8th, 2024

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer goods, and other industries. Powered by RheoGuide™ Software, a streamlined, modern touc...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 10th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing — Oct 8th, 2024

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer goods, and other industries. Powered by RheoGuide™ Software, a streamlined, modern touc...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 10th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing — Oct 8th, 2024

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer goods, and other industries. Powered by RheoGuide™ Software, a streamlined, modern touc...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing — Oct 8th, 2024

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer goods, and other industries. Powered by RheoGuide™ Software, a streamlined, modern touc...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 10th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing — Oct 8th, 2024

News Summary: Easy-to-use, compact analyzer makes rheological insights more accessible to quality testing laboratories and material production facilities in batteries, pharmaceuticals, food, consumer goods, and other industries. Powered by RheoGuide™ Software, a streamlined, modern touc...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 14th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 10th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 10th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 10th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Waters Corporation Schedules Third Quarter 2024 Earnings Conference Call — Oct 7th, 2024

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at htt...

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis — Oct 10th, 2024

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA seque...

Should We Be Delighted With Waters Corporation's (NYSE:WAT) ROE Of 42%? — Oct 3rd, 2024

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand Waters Cor...